These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2481032

  • 1. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat.
    Tanaka H, Okada Y, Kawagishi M, Tokiwa T.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1199-203. PubMed ID: 2481032
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H, Satake-Ishikawa R, Ishikawa M, Matsuki S, Asano K.
    Cancer Res; 1991 Jul 15; 51(14):3710-4. PubMed ID: 1712246
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
    Tanaka H, Tokiwa T.
    J Pharmacol Exp Ther; 1990 Nov 15; 255(2):724-9. PubMed ID: 1700818
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
    Tanaka H, Kaneko T.
    Drug Metab Dispos; 1991 Nov 15; 19(1):200-4. PubMed ID: 1708329
    [Abstract] [Full Text] [Related]

  • 5. Sex differences in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat.
    Tanaka H, Kaneko T.
    Drug Metab Dispos; 1991 Nov 15; 19(6):1034-9. PubMed ID: 1724959
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and pharmacodynamic comparisons between human granulocyte colony-stimulating factor purified from human bladder carcinoma cell line 5637 culture medium and recombinant human granulocyte colony-stimulating factor produced in Escherichia coli.
    Tanaka H, Kaneko T.
    J Pharmacol Exp Ther; 1992 Jul 15; 262(1):439-44. PubMed ID: 1625212
    [Abstract] [Full Text] [Related]

  • 7. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Shinagawa K, Tabata M, Hirano A, Mizunuma N.
    Gan To Kagaku Ryoho; 1989 May 15; 16(5):2005-12. PubMed ID: 2471461
    [Abstract] [Full Text] [Related]

  • 8. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N, Asano S, Matsuda S, Watari K, Takaku F, Nagata S.
    Exp Hematol; 1989 Feb 15; 17(2):116-9. PubMed ID: 2463930
    [Abstract] [Full Text] [Related]

  • 9. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 11. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat.
    Tanaka H, Tokiwa T.
    Cancer Res; 1990 Oct 15; 50(20):6615-9. PubMed ID: 1698539
    [Abstract] [Full Text] [Related]

  • 12. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Oct 15; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C, Uchiyama H, Fujita N, Araki S, Sudo Y, Yamagata N, Ashihara E, Goto H, Inaba T, Haruyama H.
    Exp Hematol; 1995 Dec 15; 23(14):1497-502. PubMed ID: 8542937
    [Abstract] [Full Text] [Related]

  • 14. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M, Kawanishi Y, Kuriyama K, Kuratsuji T, Toyama K.
    Rinsho Ketsueki; 1990 Apr 15; 31(4):484-6. PubMed ID: 1696326
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S, Mizorogi F, Inoue T, Sudo K, Ohnishi A.
    Bone Marrow Transplant; 2000 Nov 15; 26(9):939-46. PubMed ID: 11100272
    [Abstract] [Full Text] [Related]

  • 16. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
    Tanaka H, Tanaka Y, Shinagawa K, Yamagishi Y, Ohtaki K, Asano K.
    Cytokine; 1997 May 15; 9(5):360-9. PubMed ID: 9195136
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H.
    Pediatr Res; 1990 Jun 15; 27(6):612-6. PubMed ID: 1694023
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice.
    Fukuhara N, Ohnishi N, Mori T, Ozawa A.
    Tokai J Exp Clin Med; 1990 May 15; 15(2-3):261-2. PubMed ID: 1718058
    [Abstract] [Full Text] [Related]

  • 19. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N, Chertkov J, Zander A.
    Exp Hematol; 1995 Oct 15; 23(11):1180-6. PubMed ID: 7556528
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M.
    Bone Marrow Transplant; 2001 Aug 15; 28(4):329-34. PubMed ID: 11571503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.